nelfinavir has been researched along with Leukemia, Lymphoblastic, Acute, T Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aplan, PD; Chang, YS; Della Gatta, G; Dennis, PA; Ferrando, AA; Gills, JJ; Kawabata, S; Onozawa, M | 1 |
1 other study(ies) available for nelfinavir and Leukemia, Lymphoblastic, Acute, T Cell
| Article | Year |
|---|---|
Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia.
Topics: Amyloid Precursor Protein Secretases; Animals; Cell Line, Tumor; Enzyme Inhibitors; Humans; Mice; Mice, Transgenic; Nelfinavir; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Presenilin-1; Proto-Oncogene Proteins c-akt; Receptor, Notch1; RNA, Messenger; Sestrins; TOR Serine-Threonine Kinases; Transcription Factors | 2023 |